J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like Cantrell Drug Company Files for Chapter 11 Bankruptcy November 7, 2017 Array BioPharma Touts Phase III Results for Melanoma Therapy March 21, 2018 Biogen Loses Yet Another Top Exec May 25, 2017
